PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW176941View Pathway |
drug action
Cefprozil Action PathwayEscherichia coli
Cefprozil is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Cefprozil exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:18 Last Updated: January 02, 2024 at 09:18 |
PW145238View Pathway |
drug action
Cefprozil Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:22 Last Updated: October 07, 2023 at 15:22 |
PW176946View Pathway |
drug action
Cefradine Action PathwayEscherichia coli
Cefradine is a first-generation cephalosporin antibiotic used in the treatment of bacterial infections of the respiratory and urinary tracts and of the skin and soft tissues. Cefradine exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:18 Last Updated: January 02, 2024 at 09:18 |
PW145381View Pathway |
drug action
Cefradine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:42 Last Updated: October 07, 2023 at 15:42 |
PW175996View Pathway |
Cefradine Predicted Metabolism Pathway newHomo sapiens
Metabolites of Cefradine are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:06 Last Updated: November 29, 2023 at 13:06 |
PW145719View Pathway |
drug action
Ceftaroline fosamil Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:28 Last Updated: October 07, 2023 at 16:28 |
PW176935View Pathway |
drug action
Ceftazidime Action PathwayEscherichia coli
Ceftazidime is an injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia. Ceftazidime exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:16 Last Updated: January 02, 2024 at 09:16 |
PW144563View Pathway |
drug action
Ceftazidime Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:54 Last Updated: October 07, 2023 at 13:54 |
PW176948View Pathway |
drug action
Ceftibuten Action PathwayEscherichia coli
Ceftibuten is a third-generation cephalosporin antibiotic commonly used in the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsillitis. Ceftibuten exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:18 Last Updated: January 02, 2024 at 09:18 |
PW145421View Pathway |
drug action
Ceftibuten Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:47 Last Updated: October 07, 2023 at 15:47 |